Minireviews
Copyright ©The Author(s) 2019.
World J Gastrointest Endosc. Feb 16, 2019; 11(2): 84-94
Published online Feb 16, 2019. doi: 10.4253/wjge.v11.i2.84
Figure 1
Figure 1 Overview of endoscopic surveillance of primary sclerosing cholangitis. AASLD: American Association for the Study of Liver Diseases; CA 19-9: Carbohydrate antigen 19-9 serum tumor marker; EGD: Esophagogastroduodenoscopy; PSC: Primary sclerosing cholangitis; PSC-IBD: Inflammatory bowel disease co-existing with primary sclerosing cholangitis.